Predicting dangerous heart rhythms in non-ischemic heart disease
Part of Genetic & congenital, Heart & circulation clinical trials.
This study uses heart MRI scans to predict who might develop dangerous heart rhythms. It's for people with certain types of non-ischemic heart disease who have already had an MRI with contrast.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a non-ischemic heart disease that affects the left ventricle, such as dilated cardiomyopathy, non-dilated left ventricular cardiomyopathy, or heart muscle inflammation after a viral infection.
- You have had at least one heart MRI with contrast (called LGE-CMR) in the past.
- You did not have a dangerous heart rhythm event at the time of your first heart MRI.
- Your life expectancy is more than 1 year and you feel generally well (NYHA class better than IV).
- You are not pregnant and do not have other structural heart conditions like blockages in the arteries or congenital heart defects.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses heart MRI scans to predict who might develop dangerous heart rhythms after recovering from myocarditis. It aims to find better ways to monitor patients and prevent emergencies.
This trial uses a heart MRI to measure details in people with dilated cardiomyopathy and reduced pumping strength. It aims to use these MRI findings to better predict your future heart risk and guide care.
This study tests whether using a special heart MRI to guide the placement of an implantable defibrillator (ICD) is safe and effective in people with dilated, non-ischemic cardiomyopathy and reduced heart pumping. It may help improve how accurately the device is positioned and support better care planning.
This study looks at how the heart's electrical signals can predict sudden cardiac arrest in people with a weakened heart muscle. It may help doctors identify who is at highest risk.
This trial uses heart MRI images and measurements to look for warning signs that could predict sudden cardiac death. It focuses on people with significantly reduced heart pumping function who are being considered for an ICD to prevent sudden death.
This research uses cardiac MRI scans and patient data to better predict outcomes in people with dilated cardiomyopathy—a condition where the heart's main pumping chamber becomes enlarged and weakened. Participating could help doctors improve how they care for similar patients in the future.
Hear when a new Dilated Cardiomyopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.